Brandywine Global Investment Management, LLC Gilead Sciences, Inc. Transaction History

Brandywine Global Investment Management, LLC

$14.2 Billion
Q3 2024

A detailed history of Brandywine Global Investment Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Brandywine Global Investment Management, LLC holds 171,778 shares of GILD stock, worth $15.9 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

171,778

Holding current value

$15.9 Million

% of portfolio

0.1%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$66.59 - $83.99 $11.4 Million - $14.4 Million	171,778 New	171,778 $14.4 Million
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $66 Million - $80.5 Million	-921,710 Reduced 59.06%	638,993 $46.8 Million
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $1.88 Million - $2.13 Million	25,687 Added 1.67%	1,560,703 $126 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $28.7 Million - $31.3 Million	388,482 Added 33.88%	1,535,016 $115 Million
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $27.2 Million - $31 Million	357,482 Added 45.31%	1,146,534 $88.4 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $2.45 Million - $2.79 Million	31,648 Added 4.18%	789,052 $65.5 Million
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $3.28 Million - $4.71 Million	-52,590 Reduced 6.49%	757,404 $65 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $831,476 - $949,759	-13,965 Reduced 1.69%	809,994 $50 Million
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $2.85 Million - $3.21 Million	-49,301 Reduced 5.65%	823,959 $50.9 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $2.44 Million - $3.06 Million	-42,203 Reduced 4.61%	873,260 $51.9 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $2.64 Million - $2.99 Million	40,625 Added 4.64%	915,463 $66.5 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $59.2 Million - $63.9 Million	874,838 New	874,838 $61.1 Million
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $60.1 Million - $68.5 Million	-1,061,493 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $2.32 Million - $2.92 Million	-37,427 Reduced 3.41%	1,061,493 $67.1 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $16.4 Million - $19 Million	-226,543 Reduced 17.09%	1,098,920 $84.6 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $26.8 Million - $34.3 Million	-427,396 Reduced 24.38%	1,325,463 $99.1 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $3.6 Million - $3.96 Million	58,355 Added 3.44%	1,752,859 $114 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $6.86 Million - $7.57 Million	-109,686 Reduced 6.08%	1,694,504 $107 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $1.83 Million - $2.06 Million	-29,655 Reduced 1.62%	1,804,190 $122 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $5.85 Million - $6.55 Million	93,552 Added 5.38%	1,833,845 $119 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $8.16 Million - $10.7 Million	-134,860 Reduced 7.19%	1,740,293 $109 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $4.39 Million - $4.86 Million	-61,618 Reduced 3.18%	1,875,153 $145 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $1.98 Million - $2.31 Million	-30,548 Reduced 1.55%	1,936,771 $137 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $6.49 Million - $7.91 Million	89,084 Added 4.74%	1,967,319 $148 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $47.1 Million - $55.3 Million	662,386 Added 54.48%	1,878,235 $135 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $32 Million - $38 Million	444,038 Added 57.53%	1,215,849 $98.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	771,811	771,811 $54.6 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.

Account

Brandywine Global Investment Management, LLC Gilead Sciences, Inc. Transaction History